Biotechnology News and Research

RSS

VIB-Ghent University research provides insights into septic shock

Researchers at VIB and Ghent University have discovered an important mechanism of sepsis, an overreaction of the body's immune system to an infection.

14 Sep 2016

Scientists uncover new role of ChAT enzyme in regulating blood pressure

In a study published today in the prestigious journal Nature Biotechnology, scientists from The Feinstein Institute for Medical Research and Karolinska Institutet discovered that T-cells capable of producing the neurotransmitter acetylcholine can regulate blood pressure.

13 Sep 2016

Researchers find innovative and cost-effective ways to remove PFAS from water supply

Elevated levels of perfluoroalkyl substances (PFASs) in drinking water can persist in water supplies for long periods and present an important health risk for millions of Americans, from hormone suppression to potentially cancer.

9 Sep 2016

International conference on longevity to be held in Brussels for 3 days

The Eurosymposium on Healthy Ageing is an international event that provides a unique opportunity for researchers, government officials, biotech executives, entrepreneurs, and non-governmental institutions from around the world to meet, network, and forge new scientific collaborations.

9 Sep 2016

Medical errors may be prevented by shifting to integrative model of healthcare

Medical errors are the third leading cause of death in the U.S. according to a published estimate, but many could be prevented with a shift in the medical industry from a production-driven to an integrative model of healthcare.

9 Sep 2016

Study points out critical need for new interventions to prevent suicide among SGM youth

Homosexual, bisexual, and transgender youth tend to have a higher risk for suicide-related thoughts and behaviors, but research on interventions to prevent suicide among sexual and gender minority (SGM) youth has been limited.

9 Sep 2016

Novel Trojan Horse antibody strategy may target Ebola's Achilles' heel

In research published online today in Science, a team of scientists describe a new therapeutic strategy to target a hidden Achilles' heel shared by all known types of Ebola virus.

8 Sep 2016

Novel technique offers new insights into growth variation across single cells

A new technique invented at MIT can precisely measure the growth of many individual cells simultaneously.

5 Sep 2016

Edinburgh Research & Innovation announces new AIMday programme to tackle challenges of infectious diseases

With viruses such as Ebola, MERS-CoV and Zika making global headlines, and the progressive development of antimicrobial resistance (AMR) worldwide, Edinburgh Research & Innovation (ERI), the commercialisation arm of the University of Edinburgh, has announced a new AIMday (Academic Industry Meeting day) for companies looking to find expertise and innovative solutions to dealing with the challenges of microbial infection.

2 Sep 2016

Mayo Clinic offers CDC’s Zika virus screening test

Mayo Clinic will offer the Zika virus antibody test developed by the Centers for Disease Control and Prevention.

1 Sep 2016

Research findings could lead to new biomarker for early stages of tumor development

To treat or not to treat? That is the question researchers at the Department of Energy's Lawrence Berkeley National Laboratory hope to answer with a new advance that could help doctors and their cancer patients decide if a particular therapy would be worth pursuing.

31 Aug 2016

MRSA correlated to eczema? An interview with Dr Bjorn Herpers

There is a lot of evidence that Staphylococcus aureus (S. aureus) is involved in eczema. Eczema is now thought to be caused by a barrier dysfunction of the skin that allows external triggers to cause an overshoot of inflammation.

31 Aug 2016

Scientists find way to use CRISPR/Cas9 technology to diagnose and inactivate cancer mutations

As for many other biomedical and biotechnology disciplines, the genome scissor "CRISPR/Cas9" also opens up completely new possibilities for cancer research.

31 Aug 2016

Mitosis study identifies new potential target for cancer therapy

Structural biologists show in a new study that an apparently key step in the process of cell division depends on a unique interaction among specific proteins, including one that is strongly linked to cancer. Their hope now is that the detailed new characterization of the interaction will make it a target for exploring a new cancer therapy.

31 Aug 2016

Can-Fite BioPharma reports financial results, provides update on drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the six months ended June 30, 2016 and updates on its drug development programs.

27 Aug 2016

Fiocruz to start phase II clinical trials of novel vaccine for schistosomiasis

The Oswaldo Cruz Foundation at Rio de Janeiro, Brazil, will start the phase II clinical trials of a vaccine for schistosomiasis, called 'Sm14 Vaccine'.

26 Aug 2016

Novel inhibitory brain receptor reduces seizure-like activity in pubertal mice

More than half of children with epilepsy outgrow their seizures, yet the mechanism underlying this remission is unknown.

26 Aug 2016

Researchers discover novel pathway for immune recovery following bone-marrow transplantation

New research has shown how a cell surface molecule, Lymphotoxin β receptor, controls entry of T-cells into the thymus; and as such presents an opportunity to understanding why cancer patients who undergo bone-marrow transplant are slow to recover their immune system.

25 Aug 2016

New UCF technology for destroying metastatic breast cancer cells licensed for clinical trials

A University of Central Florida cancer researcher has discovered a way to kill spreading breast cancer cells and her new technology has generated a licensing agreement that will accelerate the therapy's path to clinical trials.

25 Aug 2016

HMS study reveals key instigator of nerve cell damage in ALS patients

Scientists from Harvard Medical School have identified a key instigator of nerve cell damage in people with amyotrophic lateral sclerosis, or ALS, a progressive and incurable neurodegenerative disorder.

25 Aug 2016

Biotechnology News and Research

VIB-Ghent University research provides insights into septic shock

Scientists uncover new role of ChAT enzyme in regulating blood pressure

Researchers find innovative and cost-effective ways to remove PFAS from water supply

International conference on longevity to be held in Brussels for 3 days

Medical errors may be prevented by shifting to integrative model of healthcare

Study points out critical need for new interventions to prevent suicide among SGM youth

Novel Trojan Horse antibody strategy may target Ebola's Achilles' heel

Novel technique offers new insights into growth variation across single cells

Edinburgh Research & Innovation announces new AIMday programme to tackle challenges of infectious diseases

Mayo Clinic offers CDC’s Zika virus screening test

Research findings could lead to new biomarker for early stages of tumor development

MRSA correlated to eczema? An interview with Dr Bjorn Herpers

Scientists find way to use CRISPR/Cas9 technology to diagnose and inactivate cancer mutations

Mitosis study identifies new potential target for cancer therapy

Can-Fite BioPharma reports financial results, provides update on drug development programs

Fiocruz to start phase II clinical trials of novel vaccine for schistosomiasis

Novel inhibitory brain receptor reduces seizure-like activity in pubertal mice

Researchers discover novel pathway for immune recovery following bone-marrow transplantation

New UCF technology for destroying metastatic breast cancer cells licensed for clinical trials

HMS study reveals key instigator of nerve cell damage in ALS patients

Biotechnology eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News